Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
AbSci Establishes New Collaboration with Sanofi
Thursday, January 10, 2019AbSci a global leader in biotherapeutic discovery and manufacturing technologies today announced a collaboration with Sanofi Under the terms of the agreement AbSci will apply its breakthrough Ecoli manufacturing platform SoluProTM and its novel optim...
SIRION Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System
Thursday, January 10, 2019SIRION Biotech GmbH a world leader in viral vectorbased gene delivery technologies for gene cell therapy announced today that it signed a license and collaboration agreement with Denali Therapeutics a biopharmaceutical company developing a broad por...
Ascentage Pharma Announces New License with Unity Biotechnology
Wednesday, January 09, 2019Ascentage Pharma a global clinicalstage biopharmaceutical company dedicated to developing apoptosistargeted therapies for cancers and other diseases today announced that Unity Biotechnology Inc has selected one of Ascentages compounds as its lead dev...
Generex Biotechnology Completes Acquisition of Olaregen Therapeutix Inc.
Wednesday, January 09, 2019Generex Biotechnology Corporation is pleased to announce that the company has completed the acquisition of of Olaregen Therapeutix Inc a New York based regenerative medicine company that is preparing to launch its proprietary patented wound conformi...
Ascentage Pharma and MD Anderson Cancer Center Announce Strategic Alliance in Cancer Drug Development
Tuesday, January 08, 2019Ascentage Pharma Group Inc and The University of Texas MD Anderson Cancer Center today announced a fiveyear strategic collaboration agreement to advance the development of five potential new cancer therapies The alliance is aimed at developing nov...
Fedora Pharmaceuticals and Meiji Seika Pharma Sign Basic Agreement to Establish NacuGen Therapeutics Inc., a Joint Venture
Tuesday, January 08, 2019Fedora Pharmaceuticals Inc and Meiji Seika Pharma announced today that they have signed a basic agreement to establish NacuGen Therapeutics Inc a joint venture that will be dedicated to the development and commercialization of novel antiinfectives in...
Adaptive Biotechnologies to Enter into Worldwide Collaboration and License Agreement with Genentech to Develop Personalized Cellular Therapies
Monday, January 07, 2019Adaptive Biotechnologies an immunedriven medicine company today announced that it will enter into a worldwide collaboration and license agreement with Genentech a member of the Roche Group to develop manufacture and commercialize novel neoantigen dir...
AmpliPhi Biosciences and C3J Therapeutics Agree to Merge
Monday, January 07, 2019AmpliPhi Biosciences Corporation a clinicalstage biotechnology company focused on the development of precisely targeted bacteriophage therapeutics for antibioticresistant infections and CJ Therapeutics Inc CJ a private clinical stage biotechnology co...
Flex Pharma and Salarius Pharmaceuticals Announce Merger Agreement to Accelerate Clinical Development of Novel Epigenetic Therapy for Cancer
Saturday, January 05, 2019Flex Pharma Inc and Salarius Pharmaceuticals LLC a clinicalstage oncology company targeting the epigenetic causes of cancers today announced that the companies have entered into a definitive merger agreement under which privatelyheld Salarius will me...
Otsuka and Click Therapeutics Collaborate to Develop and Commercialize Digital Therapeutics for Patients with Major Depressive Disorder
Saturday, January 05, 2019Otsuka America Inc and Click Therapeutics Inc announce today that the companies have signed a collaboration agreement to develop and commercialize a prescription digital therapeutic for treatment of Major Depressive Disorder MDD with the intent to ad...
